Ignite Creation Date:
2024-05-05 @ 7:13 PM
Last Modification Date:
2024-10-26 @ 9:45 AM
Study NCT ID:
NCT00628251
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2008-02-26
Brief Title:
Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCAve Advanced Ovarian Cancer
Sponsor:
Organization:
AstraZeneca